期刊文献+

人甲型流感病毒H3N2亚型中和表位串联基因原核表达载体的构建 被引量:1

Construction of Prokaryotic Expression Vector for Multiple Neutralizing Epitopes of Human Influenza A Virus Subtype H3N2
下载PDF
导出
摘要 目的构建人甲型流感病毒H3N2亚型中和表位串联基因原核表达载体,并在大肠杆菌中表达目的蛋白。方法合成人甲型流感病毒H3N2亚型中和表位的串联基因,克隆入pET-28a(+)载体中,构建重组表达载体pET-28a-H3,经酶切鉴定和DNA序列分析后,转化大肠杆菌BL21(DE3),IPTG诱导表达,并进行ELISA和Westernblot鉴定。结果重组载体pET-28a-H3酶切片段大小和DNA序列分析与预期结果一致。表达的目的蛋白相对分子质量约9400,与相应的多克隆抗体反应性良好。结论已成功构建人甲型流感病毒H3N2亚型中和表位串联基因原核表达载体pET-28a-H3,并表达了目的蛋白,为制备单克隆和多克隆抗体奠定了基础。 Objective To construct a prokaxyofic expression vector for multiple neutralizing epitopes of human influenza A virus subtype H3N2 and express in E. coli .Methods The cascaded gene of human influenza A virus subtype H3N2 was synthesized and cloned into vector pET-28a( + ). The constructed recombinant plasmid pET-28a-H3 was identified by restriction analysis and DNA sequencing,then transformed to E. coli BL21(DE3) for expression under induction of IPFG.The expressed product was identified by ELISA and Western blot.Resuits Both the length and DNA sequence of gene fragment extracted from recombinant plasmid pET-28a-H3 were consistent with those expected.The expressed protein,with a relative molecular mass of about 9 400, showed good reactivity with the corresponding polyclonal antibody. Conclusion The prokaxyotic expression vector pET-28a-H3 for multiple neutralizing epitopes of human influenza A virus subtype H3N2 was successfully constructed and expressed, which laid a foundation of preparation of monoclonal and polyclonal antibodies.
机构地区 解放军
出处 《中国生物制品学杂志》 CAS CSCD 2008年第3期178-184,共7页 Chinese Journal of Biologicals
基金 病原微生物生物安全国家重点实验室开放基金(200503)
关键词 人甲型流感病毒 H3N2亚型 中和表位 串联基因 原核表达 Human influenza virus A Subtype H3N2 Neutralizing epitopes Cascaded gene Prokaxyotic expression
  • 相关文献

参考文献14

  • 1Saad MD, Hussein HA, Bashandy MM, et al. Hepatitis E vires infection in work horses in Egypt.Infect Genet Evol,2007,7(3) :368-373.
  • 2Nakamura M,Takahashi K,Taira K,et al.Hepaitis E vires infection in wild mongooses of Okinaws, Japan: Demonstration of anti-HEV antibodies and a full-genome nucleotide sequence. Hepatol Res, 2006,34(3) :137-140.
  • 3Kuno A, Ido K, Isoda N, et al. Sporadic acute hepatitis E of a 47-year-old man whose pet cat was positive for antibody to hepatitis E vires. Hepatol Res,2003,26(3) :237-242.
  • 4Yazaki Y, Mizuo H, Takahashi M,et al.Sporadic acute or ful minant hepatitis E in Hokkaldo, Japan,may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food.J Gen Virol,2003,84(9) : 2351-2357.
  • 5Li TC, Chijiwa K, Sera N, et al. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis,2005,11(12) :1958-1960.
  • 6王凤阳,李布勇,王轶,廖起志,杜丽,李笑春,申明霞,成鹰,刘涛.海口和三亚地区商品猪中戊型肝炎病毒感染情况调查[J].中国热带医学,2007,7(6):897-897. 被引量:7
  • 7朱奕奕,李燕婷,张爱香,周研,沈荣明,沈微娟.上海地区猪戊型肝炎感染状况及病毒序列分析[J].上海预防医学,2006,18(3):103-105. 被引量:13
  • 8孙中锋,金宁一,朱光泽,屈勇刚,李红文,金扩世,田明尧.长春地区人与猪戊型肝炎病毒分子流行病学及部分基因序列分析[J].中国人兽共患病学报,2006,22(10):941-945. 被引量:12
  • 9Panda SK, Thakral D, Rehman S. Hepatitis E virus. Bey Med Virol, 2007,17(3) : 151-180.
  • 10Purdy MA, McCaustland KA, Krawczynski K,et al.Prdiminary evidence that a trpE-HEV fusion protein protects eynomolgus macaques against challenge with wild-type hepatitis E virus(HEV).J Med Virol, 1993,41 (1) :90-94.

二级参考文献30

  • 1郝东风,马正海,王艳萍,热西旦,张富春.HPV16 L1基因的原核表达及免疫反应性鉴定[J].细胞与分子免疫学杂志,2005,21(4):428-431. 被引量:3
  • 2庄辉,李凡,朱永红,朱万孚,郭晓霞.戊型肝炎病毒中国株结构区ORF2 cDNA的克隆及表达[J].中华实验和临床病毒学杂志,1995,9(1):22-24. 被引量:6
  • 3房雪峰,王立新,孟继鸿,董晨,田华,翟理杰.载体和基因片段的选择对戊型肝炎病毒基因免疫抗原表达的影响[J].细胞与分子免疫学杂志,2006,22(1):22-25. 被引量:4
  • 4Aye TT,Uchida T,Ma XZ,et al.Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China[J].Nucleic Acids Res,1992,20(13):3512.
  • 5Huang FF,Haqshenas G,Guenette DK,et al.Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States [J].J Clin Microbiol,2002,40 (4):1326-1332.
  • 6Pei Y,Yoo D.Genetic characterization and sequence heterogeneity of a Canadian isolate of Swine hepatitis E virus[J].J Clin Microbiol,2002,40(11):4021-4029.
  • 7Wu JC,Chen CM,Chiang TY,et al.Spread of hepatitis E virus among different-aged pigs:two-year survey in Taiwan [J].J Med Virol,2002,66(4):488-492.
  • 8Worm HC,van der Poel WHM,Brandstatter G.Hepatitis E:an overview[J].Microbes and infection,2002,4:657-666.
  • 9Bradley DW.Hepatitis E virus:a brief review of the biology,molecular virology,and immunology of a novel virus[J].J hepatol,1995,22(Suppl 1):140-145.
  • 10Jihong Meng,Xing Dai,Joy C,et al.Identification and characterization of the neutralization epitope(s) of the hepatitis E virus[J].Virology,2001,288:203-211.

共引文献59

同被引文献15

  • 1贾雷立,金宁一,金扩世,郑敏,金洪涛,连海,王瑞琳,李昌,鲁会军,马鸣潇,金明兰.猪流感复合多表位核酸疫苗的构建及其表达研究[J].中国生物制品学杂志,2006,19(4):333-335. 被引量:15
  • 2Hampson AW. Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat [J]. Ann Acad Med Singapore, 2008, 37 (6): 510-517.
  • 3Gerhard W, Mozdzanowska K. Zharikova D. Prospects for universal influenza virus vaccine [J]. Emerg Infect Dis, 2006, 12 (4): 569- 574.
  • 4Stoloff GA, Caparros-Wandedey W. Synthetic muhi-epitope peptides identified in silico induce protective immunity against multi- ple influenza serotypes [J]. Eur J Immunol, 2007, 37 (9): 2441- 2449.
  • 5Bui HH, Peters B, Assarsson E, et al. Ab and T cell epitopes of influenza A virus, knowledge and opportunities [J]. Proc Nail Acad Sci USA, 2007, 104 (1): 246-251.
  • 6Fan J, Liang X, Horton MS, et al. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys [J]. Vaccine, 2004, 22 (23-24): 2993-3003.
  • 7Schotsaert M, De Filette M, Fiers W, et al. Universal M2 ectodomain- based influenza A vaccines: preclinical and clinical developments [J]. Expert Rev Vaccines, 2009, 8 (4): 499-508.
  • 8Boon AC, De Mutsert G, Fouchier RAM, et ol. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxie T lymphocytes with high functional avidity [J]. J Virol, 2006, 80 (12): 6024-6032.
  • 9De Filette M, Fiers W, Martens W, et al. Improved design and intranasal delivery of an M2e-based human influenza A vaccine [J]. Vaccine, 2006, 24 (44-46): 6597-6601.
  • 10Pumpens P, Grens E. HBV core particles as a carrier for B cell / T cell epitopes [ J ]. Intervirology, 2001, 44( 2-3 ): 98-114.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部